Metropolis Healthcare Limited Share Price & Analysis
₹554.6▲ +1.19%Updated 13 May 2026, 11:32 am IST
LTP
₹554.6
+1.19%
Open
₹—
High
₹557.8
Low
₹541.3
Close
₹554.6
52W High
₹575
52W Low
₹397
Volume
168K
Lot Size
1
Sector
Healthcare
Market Cap
₹11K Cr
Face Value
₹2
Mid Cap
Price Chart
Fundamentals
P/E
65.2
Sector P/E
43.5
P/B
8.03
EPS
₹8.12
ROE
11.5%
ROCE
14.7%
D/E Ratio
0.14
Div Yield
0.18%
Book Value
₹69.1
+
Strengths
- ✓Low debt relative to equity (D/E 0.1x)
−
Concerns
- ✗High premium to book value (P/B 8x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,844 | ₹4.4L Cr | 36.5 | 5.69 | 16.9 | 20.2 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹6,711 | ₹1.8L Cr | 70.3 | 11.55 | 15.4 | 20.4 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,358 | ₹1.5L Cr | 64.3 | 17.43 | 26.5 | 27 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,057 | ₹1.2L Cr | 64.1 | 12.75 | 18.4 | 16.6 | 0.88 |
| CIPLA Cipla Limited | ₹1,306 | ₹1.1L Cr | 22.9 | 3.2 | 17.8 | 22.7 | 0.01 |
| LUPIN Lupin Limited | ₹2,238 | ₹1.1L Cr | 18.9 | 4.56 | 29.1 | 30.3 | 0.32 |
| DRREDDY Dr. Reddy's Laboratories Limited | ₹1,274 | ₹1.1L Cr | 19.4 | 2.95 | 18 | 22.7 | 0.16 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
METROPOLIS · as of Mar 2026
Promoters48.89%▼0.51
FII15.29%▼1.44
DII30.30%▲0.30
Public5.51%▲1.65
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 49.74% | 49.67% | 49.62% | 49.43% | 49.40% | 48.89% |
| FII | 21.66% | 18.90% | 18.25% | 18.56% | 16.73% | 15.29% |
| DII | 20.73% | 24.86% | 27.42% | 28.02% | 30.00% | 30.30% |
| Public | 7.87% | 6.57% | 4.69% | 3.98% | 3.86% | 5.51% |
Corporate Events
To consider and approve the audited financial results of the company for the quarter and financial year ended March 31, 2026 and dividend
Dividend12 May 2026
Bonus 3:1
Bonus19 Mar 2026
Interim Dividend - Rs 4 Per Share
Dividend10 Nov 2025
Interim Dividend - Rs 4 Per Share
Dividend16 Nov 2023
Annual General Meeting
AGM9 Aug 2023
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹406 Cr ▼5.4% | ₹429 Cr ▲11.1% | ₹386 Cr ▲11.9% | ₹345 Cr ▲6.8% | ₹323 Cr ▼7.7% | ₹350 Cr ▲11.8% | ₹313 Cr ▼5.4% | ₹331 Cr |
| Op. Profit | ₹95 Cr ▼12.0% | ₹108 Cr ▲20.0% | ₹90 Cr ▲45.2% | ₹62 Cr ▼13.9% | ₹72 Cr ▼20.0% | ₹90 Cr ▲13.9% | ₹79 Cr ▼1.3% | ₹80 Cr |
| OPM | 23.0% ▼8.0% | 25.0% ▲8.7% | 23.0% ▲27.8% | 18.0% ▼18.2% | 22.0% ▼15.4% | 26.0% ▲4.0% | 25.0% ▲4.2% | 24.0% |
| Net Profit | ₹42 Cr ▼20.8% | ₹53 Cr ▲17.8% | ₹45 Cr ▲55.2% | ₹29 Cr ▼6.5% | ₹31 Cr ▼34.0% | ₹47 Cr ▲23.7% | ₹38 Cr ▲2.7% | ₹37 Cr |
| EPS (₹) | 2 ▼21.3% | 2.54 ▲17.1% | 2.17 ▲53.9% | 1.41 ▼7.8% | 1.53 ▼32.6% | 2.27 ▲22.7% | 1.85 ▲3.9% | 1.78 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1.3K Cr ▲10.2% | ₹1.2K Cr ▲5.2% | ₹1.1K Cr ▼6.5% | ₹1.2K Cr ▲23.0% | ₹998 Cr ▲16.6% | ₹856 Cr ▲12.5% | ₹761 Cr ▲17.6% | ₹647 Cr ▲18.7% | ₹545 Cr |
| Expenses | ₹1.0K Cr ▲11.2% | ₹920 Cr ▲7.6% | ₹855 Cr ▼2.8% | ₹880 Cr ▲24.3% | ₹708 Cr ▲14.4% | ₹619 Cr ▲10.7% | ₹559 Cr ▲19.7% | ₹467 Cr ▲15.3% | ₹405 Cr |
| Op. Profit | ₹308 Cr ▲6.9% | ₹288 Cr ▼1.7% | ₹293 Cr ▼15.8% | ₹348 Cr ▲20.0% | ₹290 Cr ▲22.4% | ₹237 Cr ▲16.7% | ₹203 Cr ▲12.2% | ₹181 Cr ▲29.3% | ₹140 Cr |
| OPM | 23.0% ▼4.2% | 24.0% ▼7.7% | 26.0% ▼7.1% | 28.0% ▼3.4% | 29.0% ▲3.6% | 28.0% ▲3.7% | 27.0% ▼3.6% | 28.0% ▲7.7% | 26.0% |
| Other Income | ₹15 Cr ▲66.7% | ₹9 Cr ▼40.0% | ₹15 Cr ▼55.9% | ₹34 Cr ▲183.3% | ₹12 Cr ▲170.6% | ₹-17 Cr ▼312.5% | ₹8 Cr ▲33.3% | ₹6 Cr ▼84.6% | ₹39 Cr |
| Interest | ₹24 Cr ▼14.3% | ₹28 Cr ▼12.5% | ₹32 Cr ▲28.0% | ₹25 Cr ▲108.3% | ₹12 Cr ▼7.7% | ₹13 Cr ▲225.0% | ₹4 Cr ▲0.0% | ₹4 Cr ▲100.0% | ₹2 Cr |
| Depreciation | ₹109 Cr ▲16.0% | ₹94 Cr ▲5.6% | ₹89 Cr ▲41.3% | ₹63 Cr ▲37.0% | ₹46 Cr ▲17.9% | ₹39 Cr ▲95.0% | ₹20 Cr ▲5.3% | ₹19 Cr ▲11.8% | ₹17 Cr |
| PBT | ₹191 Cr ▲9.1% | ₹175 Cr ▼6.9% | ₹188 Cr ▼35.8% | ₹293 Cr ▲20.1% | ₹244 Cr ▲44.4% | ₹169 Cr ▼9.6% | ₹187 Cr ▲14.0% | ₹164 Cr ▲2.5% | ₹160 Cr |
| Tax % | 24.0% ▼7.7% | 26.0% ▲8.3% | 24.0% ▼11.1% | 27.0% ▲8.0% | 25.0% ▲4.2% | 24.0% ▼29.4% | 34.0% ▲6.3% | 32.0% ▼3.0% | 33.0% |
| Net Profit | ₹146 Cr ▲14.1% | ₹128 Cr ▼10.5% | ₹143 Cr ▼33.5% | ₹215 Cr ▲17.5% | ₹183 Cr ▲43.0% | ₹128 Cr ▲3.2% | ₹124 Cr ▲10.7% | ₹112 Cr ▲4.7% | ₹107 Cr |
| EPS (₹) | 7 ▲12.2% | 6.24 ▼10.6% | 6.98 ▼33.3% | 10.46 ▲16.9% | 8.95 ▲42.3% | 6.29 ▲5.0% | 5.99 ▼78.1% | 27.29 ▲2.6% | 26.61 |
| Div Payout | 0.0% ▼100.0% | 16.0% ▼44.8% | 29.0% ▲52.6% | 19.0% ▼13.6% | 22.0% ▼31.3% | 32.0% ▼41.8% | 55.0% | 0.0% ▼100.0% | 49.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||||
| Equity Capital | ₹10 Cr ▲0.0% | ₹10 Cr ▲0.0% | ₹10 Cr ▲0.0% | ₹10 Cr ▲0.0% | ₹10 Cr ▲0.0% | ₹10 Cr ▲0.0% | ₹10 Cr ▲0.0% | ₹10 Cr ▲0.0% | ₹10 Cr ▲0.0% | ₹10 Cr |
| Reserves | ₹1.4K Cr ▲7.6% | ₹1.3K Cr ▲21.6% | ₹1.1K Cr ▲11.0% | ₹978 Cr ▲11.6% | ₹876 Cr ▲25.9% | ₹696 Cr ▲35.7% | ₹513 Cr ▲25.7% | ₹408 Cr ▲0.7% | ₹405 Cr ▲29.0% | ₹314 Cr |
| Borrowings | ₹201 Cr ▼1.5% | ₹204 Cr ▲3.6% | ₹197 Cr ▼25.9% | ₹266 Cr ▼29.8% | ₹379 Cr ▲238.4% | ₹112 Cr ▲67.2% | ₹67 Cr ▲272.2% | ₹18 Cr ▲1700.0% | ₹1 Cr ▲0.0% | ₹1 Cr |
| Other Liabilities | ₹359 Cr ▲10.8% | ₹324 Cr ▲27.6% | ₹254 Cr ▲5.8% | ₹240 Cr ▼6.3% | ₹256 Cr ▲41.4% | ₹181 Cr ▲13.1% | ₹160 Cr ▲41.6% | ₹113 Cr ▲2.7% | ₹110 Cr ▼41.5% | ₹188 Cr |
| Total Liabilities | ₹2.0K Cr ▲7.2% | ₹1.9K Cr ▲20.2% | ₹1.5K Cr ▲3.5% | ₹1.5K Cr ▼1.7% | ₹1.5K Cr ▲52.1% | ₹1.0K Cr ▲33.3% | ₹750 Cr ▲36.4% | ₹550 Cr ▲4.6% | ₹526 Cr ▲2.7% | ₹512 Cr |
| Assets | ||||||||||
| Fixed Assets | ₹1.6K Cr ▲8.7% | ₹1.4K Cr ▲22.9% | ₹1.2K Cr ▲5.0% | ₹1.1K Cr ▲5.9% | ₹1.1K Cr ▲208.7% | ₹343 Cr ▲15.9% | ₹296 Cr ▲39.0% | ₹213 Cr ▲2.9% | ₹207 Cr ▲2.5% | ₹202 Cr |
| CWIP | ₹0 Cr | ₹0 Cr | ₹0 Cr ▼100.0% | ₹20 Cr ▲233.3% | ₹6 Cr | ₹0 Cr ▼100.0% | ₹3 Cr ▼50.0% | ₹6 Cr | ₹0 Cr ▼100.0% | ₹1 Cr |
| Investments | ₹21 Cr ▼70.4% | ₹71 Cr ▲29.1% | ₹55 Cr ▲266.7% | ₹15 Cr ▼6.3% | ₹16 Cr ▲60.0% | ₹10 Cr ▼28.6% | ₹14 Cr ▼57.6% | ₹33 Cr ▼67.6% | ₹102 Cr ▼28.2% | ₹142 Cr |
| Other Assets | ₹399 Cr ▲17.0% | ₹341 Cr ▲7.9% | ₹316 Cr ▼7.1% | ₹340 Cr ▼22.7% | ₹440 Cr ▼32.0% | ₹647 Cr ▲48.1% | ₹437 Cr ▲46.6% | ₹298 Cr ▲38.0% | ₹216 Cr ▲29.3% | ₹167 Cr |
| Total Assets | ₹2.0K Cr ▲7.2% | ₹1.9K Cr ▲20.2% | ₹1.5K Cr ▲3.5% | ₹1.5K Cr ▼1.7% | ₹1.5K Cr ▲52.1% | ₹1.0K Cr ▲33.3% | ₹750 Cr ▲36.4% | ₹550 Cr ▲4.6% | ₹526 Cr ▲2.7% | ₹512 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹263 Cr ▼0.4% | ₹264 Cr ▲6.9% | ₹247 Cr ▼2.4% | ₹253 Cr ▲1.6% | ₹249 Cr ▲15.8% | ₹215 Cr ▲138.9% | ₹90 Cr ▼13.5% | ₹104 Cr ▲2.0% | ₹102 Cr ▲12.1% | ₹91 Cr |
| Investing CF | ₹-199 Cr ▼123.6% | ₹-89 Cr ▼285.4% | ₹48 Cr ▲106.5% | ₹-736 Cr ▼1268.3% | ₹63 Cr ▲160.6% | ₹-104 Cr ▼388.9% | ₹36 Cr ▲3500.0% | ₹1 Cr ▲101.2% | ₹-86 Cr ▼189.6% | ₹96 Cr |
| Financing CF | ₹-87 Cr ▲51.9% | ₹-181 Cr ▲38.0% | ₹-292 Cr ▼279.1% | ₹163 Cr ▲593.9% | ₹-33 Cr ▲40.0% | ₹-55 Cr ▲53.4% | ₹-118 Cr ▼35.6% | ₹-87 Cr ▼411.8% | ₹-17 Cr ▲90.2% | ₹-174 Cr |
| Net Cash Flow | ₹-23 Cr ▼283.3% | ₹-6 Cr ▼300.0% | ₹3 Cr ▲100.9% | ₹-321 Cr ▼215.1% | ₹279 Cr ▲398.2% | ₹56 Cr ▲600.0% | ₹8 Cr ▼55.6% | ₹18 Cr ▲1900.0% | ₹-1 Cr ▼107.1% | ₹14 Cr |
| Free Cash Flow | ₹196 Cr ▼2.0% | ₹200 Cr ▲2.6% | ₹195 Cr ▼12.6% | ₹223 Cr ▲0.9% | ₹221 Cr ▲23.5% | ₹179 Cr ▲167.2% | ₹67 Cr ▼25.6% | ₹90 Cr ▲100.0% | ₹45 Cr ▼43.0% | ₹79 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 41d ▲7.9% | 38d ▼2.6% | 39d ▼2.5% | 40d ▼11.1% | 45d ▼18.2% | 55d ▼16.7% | 66d ▲15.8% | 57d ▲5.6% | 54d ▲0.0% | 54d |
| Inventory Days | 65d ▲12.1% | 58d ▼9.4% | 64d ▼5.9% | 68d ▲15.3% | 59d ▲34.1% | 44d ▼20.0% | 55d ▲3.8% | 53d ▲39.5% | 38d ▼17.4% | 46d |
| Days Payable | 171d ▲14.0% | 150d ▲10.3% | 136d ▲0.0% | 136d ▼15.0% | 160d ▲5.3% | 152d ▲68.9% | 90d ▲2.3% | 88d ▼9.3% | 97d ▲1.0% | 96d |
| Cash Conv. Cycle | -65d ▼22.6% | -53d ▼60.6% | -33d ▼13.8% | -29d ▲48.2% | -56d ▼3.7% | -54d ▼280.0% | 30d ▲42.9% | 21d ▲520.0% | -5d ▼266.7% | 3d |
| Working Capital Days | -18d ▼12.5% | -16d ▲27.3% | -22d ▲15.4% | -26d ▼188.9% | -9d ▼550.0% | 2d ▼93.9% | 33d ▲17.9% | 28d ▲203.7% | -27d ▼437.5% | 8d |
| ROCE | 15.0% ▼6.3% | 16.0% ▼5.9% | 17.0% ▼41.4% | 29.0% ▼19.4% | 36.0% ▼10.0% | 40.0% ▼7.0% | 43.0% ▲0.0% | 43.0% ▼6.5% | 46.0% ▲35.3% | 34.0% |
Source: Screener.in · Lower days = better efficiency
Related Analysis
Frequently Asked Questions
What is Metropolis Healthcare Limited share price today?▾
Metropolis Healthcare Limited (METROPOLIS) is currently trading at ₹554.6 on NSE, up 1.19% as of the last market session. Prices update daily after market close on MarketNetra.
Is Metropolis Healthcare Limited available in F&O (Futures & Options)?▾
Yes, Metropolis Healthcare Limited (METROPOLIS) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Metropolis Healthcare Limited 52-week high and low?▾
Metropolis Healthcare Limited's 52-week high is ₹575 and the 52-week low is ₹397. The current price of ₹554.6 is 3.5% below the 52W high.
What is Metropolis Healthcare Limited P/E ratio?▾
Metropolis Healthcare Limited's current P/E ratio is 65.2. This indicates the market is paying ₹65.2 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Metropolis Healthcare Limited options?▾
Metropolis Healthcare Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade METROPOLIS options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.